Company / PP&E (Net)
Regenerative Medical Technology Group Inc. PP&E (Net) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$870.8K
FY2025
5-year range
$22.9K / $870.8K
FY2021-FY2025
Trend
+92.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E (Net) has increased for 5 consecutive years, from $2,200 in FY2020 to $870,759 in FY2025.
Based on SEC 10-K filings.
$870,759 in FY2025 with a 5-year CAGR of +230.7%.
Improved from $359,303 to $870,759 over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +67.2%
- 5-Year CAGR
- +230.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- Regenerative Medical Technology Group Inc.'s pp&e (net) has grown for 5 consecutive years.
- 5-year CAGR of +230.7%, indicating consistent growth.
- In FY2025, pp&e (net) increased 92.8% year-over-year.
- Lowest pp&e (net) in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -19.75 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $870.8K | +92.8% |
| FY2024 | $451.7K | +25.7% |
| FY2023 | $359.3K | +92.9% |
| FY2022 | $186.3K | +713.1% |
| FY2021 | $22.9K | +941.3% |
| FY2020 | $2.2K | -26.7% |
| FY2019 | $3.0K | -21.1% |
| FY2018 | $3.8K | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026